Mawaribuchi, S., Haramoto, Y., Tateno, H., Onuma, Y., Aiki, Y., & Ito, Y. (2020). rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma. FEBS Open Bio.
Style de citation ChicagoMawaribuchi, Shuuji, Yoshikazu Haramoto, Hiroaki Tateno, Yasuko Onuma, Yasuhiko Aiki, et Yuzuru Ito. "RBC2LCN Lectin As a Potential Probe of Early‐stage HER2‐positive Breast Carcinoma." FEBS Open Bio 2020.
Style de citation MLAMawaribuchi, Shuuji, et al. "RBC2LCN Lectin As a Potential Probe of Early‐stage HER2‐positive Breast Carcinoma." FEBS Open Bio 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.